The successful collaboration between Thoratec and clinicians is vital to the goal of elevating awareness of the life-restoring benefits of MCS, delivering the
therapy in a safe and effective way, and addressing a vastly underserved
patient population.

To that end, Thoratec dedicates significant resources toward providing broad-based services and support for our partners in the medical
community, including:

• A team of over 30 individuals providing 24/7 clinical/technical support;
• A team of over 25 individuals focused on market development and
  cardiology outreach;
• Extensive training and education programs, materials and personnel;
• Reimbursement and Joint Commission certification support;
• Ongoing post-market research activities; and
• Comprehensive programs aimed at continually improving clinical outcomes.

Partnering with the clinical community isn’t just something we do. It’s who we are.

“The relationship we have with our clinicians and patient ambassadors is really unique—and it’s one where there’s a great sense of camaraderie, different than what you may see in other industries. There’s really a sense of teamwork
in that we’re all in this together, trying to advance VAD therapy.”
Ed Smith, Territory Manager, Thoratec Corporation